2022 Dec 1;4:100047
Postmenopausal women or individuals at risk for bonemuscle interaction decline
Because of the unknown potential for serious adverse reactions in the breastfed infant due to the possible accumulation of SNAC from breastfeeding and because semaglutide injection can be considered for use during lactation, advise patients that breastfeeding is not recommended during treatment with oral semaglutide tablets
Emerging research has identified GLP-1 receptor expression in kidney tissue and the urinary tract, suggesting that semaglutide may have direct effects on urinary tract biology that we are only beginning to understand
The Wegovy prescribing information states that overdoses have been reported with other GLP-1 receptor agonists, with effects including severe nausea, severe vomiting and severe hypoglycemia, and that appropriate supportive treatment should be initiated according to the patients clinical signs and symptoms
Researchers observed that ipamorelin binds and activates GHSR on somatotrophs, triggering Gq-coupled phospholipase C signaling, IP3-mediated calcium release, and GH exocytosis